 | Dan Adams Mr. Daniel Adams is the Executive Chairman of Protein Sciences Corporation, a vaccine company focused primarily on using modern technology to make the next generation of safer and more effective human and animal vaccines for influenza, SARS and other diseases. Mr. Adams has previously founded and managed biopharmaceutical companies that have a current combined market value of over 40 billion dollars including Advanced Genetic Sciences Inc., Biogen Idec., AlleRx and Plant Genetic Systems. Mr. Adams holds a BA degree in Chemistry from Cornell University and a JD magna cum laude from New York University School of Law. 
|
